| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 53.5453 | 57 |
| GSM780708 | Untreated after 4 days (C2_1) | 50.2313 | 49 |
| GSM780709 | Untreated after 4 days (C3_1) | 52.3349 | 55 |
| GSM780719 | Untreated after 4 days (C1_2) | 51.5163 | 53 |
| GSM780720 | Untreated after 4 days (C2_2) | 52.6731 | 55 |
| GSM780721 | Untreated after 4 days (C3_2) | 47.3278 | 38 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 56.5605 | 61 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 47.1883 | 38 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 54.3014 | 58 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 43.2722 | 19 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 55.042 | 60 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 47.9096 | 41 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 48.5704 | 43 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 47.5503 | 39 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 52.0986 | 54 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 50.9653 | 51 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 51.751 | 53 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 50.635 | 50 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 49.4562 | 47 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 47.7185 | 40 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 52.5276 | 55 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 47.45 | 39 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 49.1903 | 46 |